Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Push Health vs Rivas Medical Weight Loss

Push Health
Graded #420

Higher grade

vs+0.6000000000000014
Rivas Medical Weight Loss
Graded #438

Lower grade

The verdict

Push Health takes it — 56.2/100 to 55.6/100, but only just.

Push Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Push Health is a large US telehealth platform that routes brand-name GLP-1 prescriptions (Ozempic, Zepbound, Mounjaro) through a 55,000+ pharmacy network. Rivas Medical Weight Loss is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRivas Medical Weight Loss +10
35
45
Dose & formulationPush Health +25
65
40
Clinical oversightRivas Medical Weight Loss +10
71
81
Labs & monitoringRivas Medical Weight Loss +1
52
53
FulfillmentPush Health +2
67
65
Contract termsEven
55
55
Push Health · left barRivas Medical Weight Loss · right bar

The numbers

MetricPush HealthRivas Medical Weight Loss
WeighScore56.2/10055.6/100
GradeCC
Scorecard rank#420#438
Semaglutide$950/mo (brand-name)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published3 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Push Health

Graded #420 · C

Strengths

  • Brand-name-only GLP-1 distribution (Ozempic, Zepbound, Mounjaro)
  • 55,000+ pharmacy network per competitor sources
  • LegitScript certified per competitor sources
  • Listed in both competitor directories

Where it loses points

  • Brand-name-only — no compounded option
  • Stub entry — exact pricing, insurance coordination, and clinician workflow need YMYL verification
  • Confidence LOW until verified

Strengths

  • Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
  • Flat price for any dose; weekly provider visits included in every payment
  • Offers both compounded semaglutide and tirzepatide

Where it loses points

  • Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
  • Only available in Maryland, Virginia, and Florida
  • Weekly-visit concierge model requires more frequent engagement than mail-order

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard